Category: <span>KRAS lung cancer</span>

New Lung Cancer Study May Improve Mesothelioma Therapy

New insight into the gene responsible for the most aggressive subtype of non-small cell lung cancer (NSCLC) could bring hope for mesothelioma patients. Researchers from UT Southwestern Medical Center identified a new way to target lung cancer through the Kirsten rat sarcoma viral oncogene homolog, also known as the KRAS gene. Tumors that carry a…

The post New Lung Cancer Study May Improve Mesothelioma Therapy appeared first on Mesothelioma Center – Vital Services for Cancer Patients & Families.